|
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (USD $)
In Thousands, except Per Share data, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Operating expenses: | |||
| Research and development | $ 35,448 | $ 25,930 | $ 21,712 |
| General and administrative | 18,159 | 15,472 | 10,518 |
| Total operating expenses | 53,607 | 41,402 | 32,230 |
| Loss from operations | (53,607) | (41,402) | (32,230) |
| Interest income | 242 | 200 | 246 |
| Net loss | (53,365) | (41,202) | (31,984) |
| Accretion of preferred stock | (6) | ||
| Net loss applicable to common stockholders | (53,365) | (41,202) | (31,990) |
| Net loss per share applicable to common stockholders-basic and diluted | $ (2.07) | $ (1.82) | $ (1.70) |
| Weighted-average number of common shares used in net loss per share applicable to common stockholders-basic and diluted | 25,804 | 22,680 | 18,765 |
| Net loss | (53,365) | (41,202) | (31,984) |
| Unrealized gains (losses) on available-for-sale securities | (17) | 6 | 24 |
| Comprehensive loss | $ (53,382) | $ (41,196) | $ (31,960) |